Laurus Labs Limited — Updates, 24-07-2026: Press Release
24-07-2026 | 02:59 pm
24-07-2026 | 02:59 pm
Laurus Labs posts strong Q1 FY27. Revenue rose 29% to ₹2,026 Cr, Net Profit surged 126% to ₹368 Cr. Growth fueled by CDMO & Affordable Medicines. Company in-licensed two ADCs and is making significant CAPEX for future expansion.
No comments yet. Be the first to comment!
